Analgesics in Latvia

Analgesics in Latvia

Consumer demand for analgesics is returning to more normal levels as Latvia recovers from the COVID-19 pandemic. The strong growth rates during the pandemic were driven by health concerns and uncertainty, as well as the surge in viral illnesses affecting consumers. Since 2023, sales of analgesics have declined as demand patterns return to normality and consumers switch to cheaper options. In the first half of 2024, seasonal cold and flu levels were way below expectation, and this dampened demand...

Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.